My time working with the manufacturer of the AstraZeneca drug substance
Little did I know then what I know now
Background
In early 2013, I was contacted by the Technical Director of the UKs HealthTech and Medicines KTN (as it was then), now Health KTN.
He explained that no UK Life Sciences company had been successful in bid submissions to the first two rounds of the UKs Advanced Manufacturing Supply Chain Initiative (AMSCI).
He went on to say that the Office for Li…
Keep reading with a 7-day free trial
Subscribe to INSIDE PHARMA to keep reading this post and get 7 days of free access to the full post archives.